⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL895442 | 0.55 | — | — | |
| Dimethyl Sulfoxide SCHEMBL14248079 | 0.50 | — | — | |
| Dimethyl Sulfoxide SCHEMBL59 | 0.50 | — | — | |
| Dimethyl Sulfoxide SCHEMBL17141374 | 0.50 | — | — | |
| Dimethyl Sulfoxide SCHEMBL2856303 | 0.50 | — | — | |
| SCHEMBL23706363 | 0.50 | — | — | |
| Dimethyl Sulfoxide SCHEMBL16720928 | 0.50 | — | — | |
| SCHEMBL4869614 | 0.47 | — | — | |
| SCHEMBL10961690 | 0.41 | — | — | |
| Potassium Ion SCHEMBL1170224 | 0.41 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3236168-A | — | — | None | — | — | JP | disclosed |
| US-20060069026-A1 | Treatment of obesity | METABOLIC PHARMACEUTICALS, LTD. | 2006-03-30 | — | — | US | disclosed |
| US-20020142965-A1 | Treatment of obesity | METABOLIC PHARMACEUTICALS, LTD. | 2002-10-03 | — | — | US | disclosed |
| US-6335319-B1 | ADMINISTERING PEPTIDE WITH AMINO ACID SEQUENCE (177-191) OF CARBOXYL-TERMINAL OF NOT INTACT, FULL-LENGTH MAMMALIAN GROWTH HORMONE; REDUCE WEIGHT GAIN AND ADIPOSE TISSUE MASS | METABOLIC PHARMACEUTICALS, INC. (AU) | 2002-01-01 | — | — | US | disclosed |
| JP-H03236168-A | CHEMICAL BATTERY | NIPPON TELEGR & TELEPH CORP <NTT> | 1991-10-22 | — | — | JP | disclosed |